Skip to main content
eLearning on BoehringerOne

A Decade of Simplicity in T2D Management: Why it Matters?

Presenters

Dr. Richard Russell
Endocrinologist
Prof. Alexander Tan, MD
  • 45 Mins

  • Self paced

    Upon completion you will earn a certificate

The aim of this webinar is to provide updates on how Linagliptin has brought improvements in diabetes care over the last 10 years. It will discuss the clinical trials of linagliptin – its efficacy, cardiovascular and renal safety and convenience across a broad range of T2D patients, and how it helps make the management of a complex disease more simple

Estimated time of Completion: 45 mins

CPD Points: 0.75 Point

PRC Program No: PROG-2022-44091

A Decade of Simplicity in T2D Management: Why it Matters? Course Outline

  • Overview of DPP4 Inhibitors
  • Linagliptin has proven efficacy and safety in a broad range of patient profiles
  • Overall Safety of Linagliptin as seen in CARMELINA® and CAROLINA®
  • Summary of clinical evidence from CVOTs in the DPP4 Inhibitor Class
  • Linagliptin + Metformin Benefits
  • Course Evaluation

PC-PH-104469 / December 2022